Hauser SL, Zielman R, Das Gupta A, Xi J, et al. Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension. Mult Scler 2023 Sep 11:13524585231195346. doi: 10.1177/13524585231195346.
PMID: 37691530